Show simple item record

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project(aEuro)

dc.contributor.authorKramar, Aen_US
dc.contributor.authorNegrier, Sen_US
dc.contributor.authorSylvester, Ren_US
dc.contributor.authorJoniau, Sen_US
dc.contributor.authorMulders, Pen_US
dc.contributor.authorPowles, Ten_US
dc.contributor.authorBex, Aen_US
dc.contributor.authorBonnetain, Fen_US
dc.contributor.authorBossi, Aen_US
dc.contributor.authorBracarda, Sen_US
dc.contributor.authorBukowski, Ren_US
dc.contributor.authorCatto, Jen_US
dc.contributor.authorChoueiri, TKen_US
dc.contributor.authorCrabb, Sen_US
dc.contributor.authorEisen, Ten_US
dc.contributor.authorEl Demery, Men_US
dc.contributor.authorFitzpatrick, Jen_US
dc.contributor.authorFlamand, Ven_US
dc.contributor.authorGoebell, PJen_US
dc.contributor.authorGravis, Gen_US
dc.contributor.authorHouede, Nen_US
dc.contributor.authorJacqmin, Den_US
dc.contributor.authorKaplan, Ren_US
dc.contributor.authorMalavaud, Ben_US
dc.contributor.authorMassard, Cen_US
dc.contributor.authorMelichar, Ben_US
dc.contributor.authorMourey, Len_US
dc.contributor.authorNathan, Pen_US
dc.contributor.authorPasquier, Den_US
dc.contributor.authorPorta, Cen_US
dc.contributor.authorPouessel, Den_US
dc.contributor.authorQuinn, Den_US
dc.contributor.authorRavaud, Aen_US
dc.contributor.authorRolland, Fen_US
dc.contributor.authorSchmidinger, Men_US
dc.contributor.authorTombal, Ben_US
dc.contributor.authorTosi, Den_US
dc.contributor.authorVauleon, Een_US
dc.contributor.authorVolpe, Aen_US
dc.contributor.authorWolter, Pen_US
dc.contributor.authorEscudier, Ben_US
dc.contributor.authorFilleron, Ten_US
dc.contributor.authorGrp, DATECANRCen_US
dc.date.accessioned2016-02-02T15:41:40Z
dc.date.available2015-07-24en_US
dc.date.issued2015-12en_US
dc.date.submitted2016-01-13T14:28:39.594Z
dc.identifier.issn0923-7534en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11012
dc.description.sponsorshipThis work was supported by grants from the French National League Against Cancer (Ligue Nationale Contre le Cancer; 2009 national grant for Clinical Research)en_US
dc.format.extent2392 - 2398en_US
dc.relation.ispartofANNALS OF ONCOLOGYen_US
dc.rights• “The final publication is available at http://annonc.oxfordjournals.org/content/26/12/2392.long”
dc.subjectclinical trialsen_US
dc.subjectDATECANen_US
dc.subjectrecommendationsen_US
dc.subjectrenal cell canceren_US
dc.subjecttime-to-event end pointsen_US
dc.titleGuidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project(aEuro)en_US
dc.typeArticle
dc.identifier.doi10.1093/annonc/mdv380en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000366374700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue12en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume26en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record